The diagnosis and treatment of minimal hepatic encephalopathy.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Deutsches Ärzteblatt International

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3238/arztebl.2012.0180PMID 22470407PMCID PMC3317375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

  2011cited by this paper
• Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

  2011cited by this paper
• Minimal Hepatic Encephalopathy Is Associated With Falls

  2011cited by this paper
• Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

  2011cited by this paper
• Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver

  2010cited by this paper
• Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

  2010cited by this paper
• Rifaximin treatment in hepatic encephalopathy.

  2010cited by this paper
• Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients

  2010cited by this paper
• The Effect of Fatigue on Driving Skills in Patients With Hepatic Encephalopathy

  2009cited by this paper
• Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test

  2009cited by this paper
• Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.

  2009cited by this paper
• Zinc deficiency

  2009cited by this paper
• Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction

  2008cited by this paper
• Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis.

  2008cited by this paper
• Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy

  2008cited by this paper
• The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy.

  2008cited by this paper
• Patients with minimal hepatic encephalopathy have poor insight into their driving skills.

  2008cited by this paper
• Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy

  2008cited by this paper
• Role of ammonia and inflammation in minimal hepatic encephalopathy

  2007cited by this paper
• Testing for minimal hepatic encephalopathy in the United States: An AASLD survey

  2007cited by this paper
• Minimal Hepatic Encephalopathy: A Vehicle for Accidents and Traffic Violations

  2007cited by this paper
• Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy

  2007cited by this paper
• Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

  2007cited by this paper
• Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

  2007cited by this paper
• Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

  2006cited by this paper
• ESPEN Guidelines on Enteral Nutrition: Liver disease.

  2006cited by this paper
• In vivo imaging of cerebral “peripheral benzodiazepine binding sites” in patients with hepatic encephalopathy

  2005cited by this paper
• Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

  2004cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Correlation between ammonia levels and the severity of hepatic encephalopathy.

  2003cited by this paper
• Critical flicker frequency for quantification of low‐grade hepatic encephalopathy

  2002cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Correlations Between Cerebral Glucose Metabolism and Neuropsychological Test Performance in Nonalcoholic Cirrhotics

  2002cited by this paper
• The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

  2001cited by this paper
• Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy

  2001cited by this paper
• CHRONIC LIVER DISEASES: EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

  2001cited by this paper
• Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

  2001cited by this paper
• Neuropsychological characterization of hepatic encephalopathy.

  2001cited by this paper
• Auditory P300 event‐related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: A follow‐up study

  2001cited by this paper
• Hepatic encephalopathy

  2001cited by this paper
• MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.

  2000cited by this paper
• Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy

  2000cited by this paper
• Spectral versus visual EEG analysis in mild hepatic encephalopathy.

  1999cited by this paper
• Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

  1999cited by this paper
• Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

  1999cited by this paper
• Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

  1998cited by this paper
• Subclinical hepatic encephalopathy impairs daily functioning

  1998cited by this paper
• Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy

  1997cited by this paper
• Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation

  1995cited by this paper
• SPECT scan and cognitive findings in subclinical hepatic encephalopathy.

  1994cited by this paper
• Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy

  1991cited by this paper
• New mode of action for lactulose.

  1988cited by this paper
• Biochemistry and physiology of brain ammonia.

  1987cited by this paper
• Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

  1977cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study

  2025cites this paper
• Impact of Helicobacter pylori Infection on the Pathogenesis of Minimal He-patic Encephalopathy and the Effects of Its Eradication

  2025cites this paper
• Mechanistic insights into the liver–brain axis during chronic liver disease

  2025cites this paper
• Emerging evidence of inter-organ interaction on drug transporters under liver injury.

  2025cites this paper
• Deploying and Examining Beacon for At-Home Patient Self-Monitoring with Critical Flicker Frequency

  2025cites this paper
• Die Alkoholdemenz

  2025cites this paper
• Prevalence of hepatic encephalopathy in non-cirrhotic portal hypertension: a systematic review and meta-analysis.

  2025cites this paper
• Meta‐analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy

  2024cites this paper
• Gut microbiota and dynamics of ammonia metabolism in liver disease

  2024cites this paper
• HEPATIC ENCEPHALOPATHY MIMICKING STROKE IN A PATIENT WITH CHRONIC LIVER DISEASE

  2024cites this paper
• Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.

  2023cites this paper
• Atlantoaxial instability associated with ALDH18A1 mutation

  2023cites this paper
• Assessment of Minimal Hepatic Encephalopathy with Brain MRI and EncephalApp Stroop Test.

  2023cites this paper
• The importance of electroencephalography in the diagnosis of hepatic encephalopathy due to cirrhosis – a case report

  2022cites this paper
• Complete, Durable Remission of Advanced Hepatocellular Carcinoma under Treatment with Viscum album Extracts: A Case Report

  2022cites this paper
• The contributions of bacteria metabolites to the development of hepatic encephalopathy

  2022cites this paper
• Exploration of the Severity of Hepatic Encephalopathy Deterioration Process Through Dynamics of the EEG Band Power time series

  2022cites this paper
• Psychometric properties of the Montreal Cognitive Assessment (MoCA) in inpatient liver transplant candidates

  2021influential citation
• Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?

  2021cites this paper
• About Minimal Hepatic Encephalopathy

  2020cites this paper
• Prevalence and Risk Factors of Minimal Hepatic Encephalopathy in Patients with Compensated Liver Cirrhosis

  2020cites this paper
• Methodische Bewertung eines elektronischen Zahlenverbindungstests (eNCT) bei Patienten mit Leberzirrhose am Beispiel der minimalen hepatischen Enzephalopathie

  2020influential citation
• Leberzirrhose und deren Komplikationen

  2020cites this paper
• Pitch Processing Can Indicate Cognitive Alterations in Chronic Liver Disease: An fNIRS Study

  2020cites this paper
• The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats

  2020cites this paper
• Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy

  2020influential citation
• Minimal Hepatic Encephalopathy among Cirrhotics A Cross Sectional, Clinico-Epidemiological, Multi-Centre, Study in Patients of Pakistan

  2019cites this paper
• Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy

  2019cites this paper
• Rapid HPLC method for monitoring of lactulose production with a high yield.

  2019cites this paper
• An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study

  2019influential citation
• Enzymatic liver function measured by LiMAx – a reliable diagnostic and prognostic tool in chronic liver disease

  2019cites this paper
• Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy.

  2019cites this paper
• The Pivotal Role of the Glutamate - glutamine Cycle in Minimal Hepatic Encephalopathy. An experimental magnetic resonance spectroscopy study

  2019cites this paper
• Nonstandardized Lactulose Administration Practice affect Hepatic Encephalopathy in Patients with Liver Disease in the Acute Care Setting ?

  2018cites this paper
• Beacon

  2018influential citation
• Astrocyte Pathophysiology in Liver Disease

  2018cites this paper
• Folgeerkrankungen bei Alkoholmissbrauch

  2018cites this paper
• Metabolisch verursachte Veränderungen des Zentralnervensystems

  2018cites this paper
• Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta‐analysis involving 826 patients based on 10 randomized controlled trials

  2018cites this paper
• A Study of EEG Alpha Wave Patterns in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

  2018cites this paper
• Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis

  2018cites this paper
• Does a Nonstandardized Lactulose Administration Practice affect Hepatic Encephalopathy in Patients with Liver Disease in the Acute Care Setting

  2018cites this paper
• Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients

  2017cites this paper
• Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.

  2017cites this paper
• Akutes Leberversagen, akut-auf-chronisches Leberversagen, hepatorenales Syndrom, hepatopulmonales Syndrom und portopulmonale Hypertonie, Leberunterstützungsverfahren auf der Intensivstation

  2017cites this paper
• Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.

  2016cites this paper
• Brain metabolism in minimal hepatic encephalopathy assessed by 3.0‐Tesla magnetic resonance spectroscopy

  2016cites this paper
• Low-light-level therapy as a treatment for minimal hepatic encephalopathy: behavioural and brain assessment

  2016cites this paper
• Impacto biopsicossocial da encefalopatia hepática

  2016cites this paper
• Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES)

  2016cites this paper
• ASSESSMENT OF LIVER ENZYMES IN PATIENT DIAGNOSTIC WITH H. PYLORI IN KHARTOUM STATE.

  2016cites this paper
• Frequency of Minimal Hepatic Encephalopathy in Cirrhotic Patients with Normal Neurological Examination

  2016cites this paper
• Current Stance of Magnetic Resonance Imaging in the Diagnosis and Monitoring of Hepatic Encephalopathy.

  2015cites this paper
• Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?

  2015cites this paper
• The role of Helicobacter pylori in minimal hepatic encephalopathy

  2015cites this paper
• Role of local and distant functional connectivity density in the development of minimal hepatic encephalopathy

  2015cites this paper
• Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy

  2015cites this paper
• Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.

  2015cites this paper
• FEATURES OF PHARMACOTHERAPY OF HEPATIC ENCEPHALOPATHY MANIFESTATIONS IN LIVER CIRRHOSIS

  2015cites this paper
• So wichtig ist die frühe Therapie!

  2014cites this paper
• Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis

  2014cites this paper
• Default Mode Network Functional Connectivity: A Promising Biomarker for Diagnosing Minimal Hepatic Encephalopathy

  2014influential citation
• The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis.

  2013cites this paper
• Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

  2013cites this paper
• Visual electrophysiological examination in diagnosis of hepatic encephalopathy

  2013cites this paper
• Synaptic plasticity in hepatic encephalopathy - a molecular perspective.

  2013cites this paper
• Minimal hepatic encephalopathy. Should we treat it?

  2013cites this paper
• Will health insurers cover the costs?

  2012cites this paper
• The Diagnosis and Treatment of Minimal Hepatic Encephalopathy

  2012cites this paper
• Restricting protein intake not beneficial.

  2012cites this paper
• Restricting Protein Intake not Beneficial Zhan and Stremmel

  year unknowncites this paper